Immunological changes following blue light cystoscopy with hexaminolevulinate in bladder cancer

被引：0
|
作者：
Elbaek, S. K. [1 ]
Young-Halvorsen, K. [2 ]
Neijber, A. [2 ]
Jensen, J. B. [3 ]
Dyrskjot, L. [1 ]
机构：
[1] Aarhus Univ Hosp, Dept Mol Med, Aarhus, Denmark
[2] Photocure ASA, Dept Global Med Affairs & Clin Dev, Oslo, Norway
[3] Aarhus Univ Hosp, Dept Urol, Aarhus, Denmark
来源：
EUROPEAN UROLOGY | 2023年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0431
引用
收藏
页码：S617 / S617
页数：1
相关论文
共 50 条
  • [41] Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: Results of a prospective phase II study
    Witjes, JA
    Moonen, PMJ
    van der Heijden, AG
    EUROPEAN UROLOGY, 2005, 47 (03) : 319 - 322
  • [42] Economic Outcomes of Hexaminolevulinate Blue-Light Cystoscopy in Non-Muscle Invasive Bladder Cancer: A 5-Year, Medicare-Based Model
    Creswell, Michael L.
    Sholklapper, Tamir N.
    Markel, Michael J.
    Mason, James B.
    Pianka, Mark A.
    Dall, Christopher P.
    Ulu, Canan
    Stamatakis, Lambros
    BLADDER CANCER, 2023, 9 (01) : 87 - 96
  • [43] BLUE LIGHT FLEXIBLE CYSTOSCOPY IN BLADDER CANCER IN AN OUTPATIENT SETTING Introduction and objectives
    Zare, Reza
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 : A53 - A53
  • [44] Hexaminolevulinate Fluorescence Cystoscopy and Transurethral Resection of the Bladder in Noninvasive Bladder Tumors
    Geavlete, Bogdan
    Multescu, Razvan
    Georgescu, Dragos
    Geavlete, Petrisor
    JOURNAL OF ENDOUROLOGY, 2009, 23 (06) : 977 - 981
  • [45] Detecting Invisible Bladder Cancers With Blue Light Cystoscopy
    Nassiri, Nima
    Maas, Marissa
    Asanad, Kian
    Daneshmand, Siamak
    UROLOGY, 2020, 139 : E8 - E9
  • [46] COST-UTILITY OF HEXAMINOLEVULINATE BLUE LIGHT CYSTOSCOPY (HAL) ASSISTED TRANSURETHRAL RESECTION OF THE BLADDER TUMOUR (TURB) COMPARED TO TURB WITH WHITE LIGHT CYSTOSCOPY (WLC) ALONE IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER (NIMBC) IN POLAND
    Jablonowski, Z.
    Konecki, T.
    Ziobro, M.
    Haldas, M.
    Wolski, Z.
    Marteau, F.
    Sosnowski, M.
    VALUE IN HEALTH, 2015, 18 (07) : A360 - A360
  • [47] Long-Term Decrease in Bladder Cancer Recurrence with Hexaminolevulinate Enabled Fluorescence Cystoscopy
    Grossman, H. Barton
    Stenzl, Arnulf
    Fradet, Yves
    Mynderse, Lance A.
    Kriegmair, Martin
    Witjes, J. Alfred
    Soloway, Mark S.
    Karl, Alexander
    Burger, Maximilian
    JOURNAL OF UROLOGY, 2012, 188 (01): : 58 - 62
  • [48] Blue-light cystoscopy's effects on management of bladder cancer when compared to traditional white-light cystoscopy
    Mount, Andrew
    Williams, Stephen Bentley
    Dinney, Colin P. N.
    Grossman, H. Barton
    Pettaway, Curtis Alvin
    Chapin, Brian Francis
    Navai, Neema
    Matin, Surena F.
    Graber, William F.
    Kamat, Ashish M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [49] A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: A phase III, multicenter study - Editorial comment
    Herr, Harry W.
    JOURNAL OF UROLOGY, 2007, 178 (01): : 73 - 73
  • [50] FLUORESCENT CYSTOSCOPY WITH HEXAMINOLEVULINATE: DIAGNOSTIC ACCURACY FOR NON-MUSCLE-INVASIVE BLADDER CANCER
    Volpe, Alessandro
    Giraudo, Davide
    Billia, Michele
    Sogni, Filippo
    Varvello, Francesco
    Zacchero, Monica
    Terrone, Carlo
    ANTICANCER RESEARCH, 2011, 31 (05) : 1904 - 1904
12345